Screener
Medline, Inc. MDLN EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Medline, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: Medline, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:48 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0002046386-26-000051
| (in millions, except per share amounts) | Three months ended / June 27, 2026 | Three months ended / June 28, 2025 | Six months ended / June 27, 2026 | Six months ended / June 28, 2025 |
|---|---|---|---|---|
| Net income attributable to Medline Inc. | $60 | $333 | $189 | $655 |
| Earnings per share attributable to Medline Inc. | ||||
| Basic | $0.07 | N/A | $0.23 | N/A |
| Diluted | $0.07 | N/A | $0.23 | N/A |
| Weighted-average number of Class A common stock outstanding | ||||
| Basic | 857 | N/A | 838 | N/A |
| Diluted | 861 | N/A | 843 | N/A |
| Other comprehensive (loss) income, net of tax |
Item 1 - Financial Statements
FAQ
- What is Medline, Inc.'s EPS (diluted)?
- Medline, Inc. (MDLN) reported EPS (diluted) of $0.07 in Q2 2026.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about Medline, Inc.'s eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude